DDrare: Database of Drug Development for Rare Diseases

224. 紫斑病性腎炎
［臨床試験数：10，薬物数：41（DrugBank：19），標的遺伝子数：15，標的パスウェイ数：56］

Searched query = "Purpura nephritis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = ACEI; Acetate; Adrenal cortical hormone; Adrenergic receptor binder (ARB); Angiotensin; Angiotensin-converting enzyme (ACE) inhibitor; Angiotensin-converting enzyme inhibitor(ACEI); Benazepril; Benazepril Hydrochloride Tablets; Calcium; Chinese herbs based on syndrome differentiation; Cyclophosphamide; Cyclophosphamide(CTX); Dipyridamole; Dipyridamole Tab 25 MG; Glycosides Of Tripterygium Wilfordii Hook(GTW); Gold; Heparin; Huaiqinhuang; Immunosuppressant; Leflunomide; Leflunomide(LEF); Low Molecular Weight Heparin Calcium Injection; MMF; Methylprednisolone; Mizoribine; Mycophenolate; Mycophenolate mofetil; Mycophenolate mofetil(MMF); Prednisone; Prednisone Acetate Tablets; Prednisone acetate; Qi-Ji Shen-Kang formula; Sulfotanshinone Sodium Injection; Tacrolimus; Tripterygium; Tripterygium Wilfordii; Tripterygium wilfordii polyglycosidium; Valsartan; Yu-Shen formula; Zhu-Bai formula

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04623866 (ClinicalTrials.gov)	November 1, 2020	25/10/2020	Study on the Treatment of Children With Purpura Nephritis With Huaiqihuang Granules	A Single Center Randomized Controlled Clinical Study on the Treatment of Children With Purpura Nephritis With Huaiqihuang Granules	Henoch Schönlein Purpura Nephritis	Drug: Huaiqinhuang;Drug: valsartan	The Children's Hospital of Zhejiang University School of Medicine	NULL	Not yet recruiting	6 Years	14 Years	All	10	Early Phase 1	China

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT04623866
(ClinicalTrials.gov)

November 1, 2020

25/10/2020

Study on the Treatment of Children With Purpura Nephritis With Huaiqihuang Granules

A Single Center Randomized Controlled Clinical Study on the Treatment of Children With Purpura Nephritis With Huaiqihuang Granules

Henoch Schönlein Purpura Nephritis

Drug: Huaiqinhuang;Drug: valsartan

The Children's Hospital of Zhejiang University School of Medicine

NULL

Not yet recruiting

6 Years

14 Years

All

Early Phase 1

China